External link, please review our disclaimer.

NIDA Consortium on Diversity Affairs

This Consortium serves as the review committee for the Diversity Supplement Program.  Below is a list of the current members.

Name Area(s) of Expertise Phone

Pamela Goodlow (Chair)

Ethnic/minority issues, research training and career development


Will Aklin

Drug abuse treatment research, treatment research in community settings, treatment of pain


Ana Anders

Ethnic populations (Hispanic/Latino and Asian American and Pacific Islander)


Debra Dudley

Grant management issues


Lynda Erinoff

Pharmacology; neuroscience; AIDS


Jerry Frankenheim

Neuroplasticity and neurotoxicology; methamphetamine; marijuana; hallucinogens


Dionne Jones

Treatment and Intervention Services for HIV/AIDS; gender differences; co-occurring disorders


Guifang Lao

Medical consequences of drug abuse and co-occurring infections; clinical molecular biology; immunology; neuroscience


Vishnudutt Purohit

Prenatal/perinatal exposure; maternal/fetal pharmacokinetics; pain/analgesia; physiological systems


Belinda Sims

Prevention; early interventions; preadolescent and adolescent drug abuse and HIV prevention; methodology research


Ericka Wells

Grants management issues



This page was last updated April 30, 2012.

Featured Publication

Featured Publication

Drugs, Brains, and Behavior - The Science of Addiction

As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.

The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services. NIH...Turning Discovery Into Health

National Institute on Drug Abuse   |   6001 Executive Boulevard, Room 5213   |   Bethesda, MD 20892-9561

Questions for our staff? E-mail information@nida.nih.gov or call 301-443-1124 (240-221-4007 en español).

Mobile Site